Chronic hepatitis C (HCV) virus infection may be associated with several non-hepatic manifestations, mainly driven by chronic im-mune stimulation, such as mixed cryoglobulinemia and Non-Hodgkin’s Lymphoma. This association has been proved by severalmeta-analyses and some interventional studies demonstrating that antiviral treatment may be effective in inducing HCV-associatedlymphoma regression. The recent advent of direct acting antivirals (DAAs) in the therapeutic armamentarium of HCV infection madepossible treatment of patients with advanced liver disease. Here we report on a rare association of a cirrhotic patient with HCV andWaldenström’s Macroglobulinemia with severe cryoglobulinemia, who had already failed an interferon-based antiviral regimen, whosehaematologic disease was ameliorated by HCV eradication following treatment with sofosbuvir and simeprevir with ribavirin, andwhere successful treatment was accompanied also by consistent improvement in liver function and parameters of portal hyperten-sion.

Improvement in Waldenstrom’s macroglobulinemia after successful treatment of HCV with direct-acting antivirals

Crespi M;Demarzo MG;Brunacci M;Pellegatta G;Ferrando F;Ballestrero A;Grillo F;Savarino V;Giannini EG
2018-01-01

Abstract

Chronic hepatitis C (HCV) virus infection may be associated with several non-hepatic manifestations, mainly driven by chronic im-mune stimulation, such as mixed cryoglobulinemia and Non-Hodgkin’s Lymphoma. This association has been proved by severalmeta-analyses and some interventional studies demonstrating that antiviral treatment may be effective in inducing HCV-associatedlymphoma regression. The recent advent of direct acting antivirals (DAAs) in the therapeutic armamentarium of HCV infection madepossible treatment of patients with advanced liver disease. Here we report on a rare association of a cirrhotic patient with HCV andWaldenström’s Macroglobulinemia with severe cryoglobulinemia, who had already failed an interferon-based antiviral regimen, whosehaematologic disease was ameliorated by HCV eradication following treatment with sofosbuvir and simeprevir with ribavirin, andwhere successful treatment was accompanied also by consistent improvement in liver function and parameters of portal hyperten-sion.
File in questo prodotto:
File Dimensione Formato  
Improvement in Waldenstorm.pdf

accesso aperto

Descrizione: pdf
Tipologia: Documento in versione editoriale
Dimensione 480.94 kB
Formato Adobe PDF
480.94 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11567/931181
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact